Equibles does not estimate personal net worth.
Get an email with a short summary when Krystal Biotech, Inc. publishes a filing, an earnings call transcript or a press release.
Get KRYS alertsSuma Krishnan is recorded as Board Member at Krystal Biotech, Inc. (KRYS) since January 1, 2016 and COO at Krystal Biotech, Inc. (KRYS). The proxy statement of Krystal Biotech, Inc. reports total compensation of $6,948,401 for Suma Krishnan in fiscal 2025, including a base salary of $677,500. Disclosed compensation is on record for 8 fiscal years. Suma Krishnan has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Krystal Biotech, Inc. on August 3, 2026. Krystal Biotech, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Krystal Biotech, Inc. includes Krish S. Krishnan (CEO and Board Member), Suma M. Krishnan (COO), John C. Thomas (General Counsel) and 3 others.
“I'm happy to share today's update and our progress. Thanks to the tireless commitment of our team, we are rapidly approaching two registrational study readouts in the front of the eye.”
“I mean, again, as you said, the good news is we have enrolled all the patients. As you may be aware, we had a natural history study that we deployed a year and a half ago.”
“I am excited to share that we are faced with two registrational study readouts expected later this year and two more in 2027.”
“It is my pleasure to share today's update on our development efforts. Thanks to the hard work of our dedicated R&D team, we are making rapid progress on our rare disease pipeline, generating breakthrough clinical data, and moving quickly towards multiple registrational data readouts later this year.”
“I would like to start today by acknowledging the hard work of our development team here at Crystal.”
2016-01-01–present
Proxy statement
Biotechnology · Healthcare
COO, Board Member
2016-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Krystal Biotech, Inc. (KRYS) | President, R&D | $677,500 | $6,948,401 |
| 2024 | Krystal Biotech, Inc. (KRYS) | President, R&D | $639,167 | $8,243,817 |
| 2023 | Krystal Biotech, Inc. (KRYS) | President, R&D | $575,000 | $3,835,481 |
| 2022 | Krystal Biotech, Inc. (KRYS) | President, R&D | $514,833 | $2,979,559 |
| 2021 | Krystal Biotech, Inc. (KRYS) | President, R&D | $453,359 | $5,123,121 |
| 2020 | Krystal Biotech, Inc. (KRYS) | President, R&D | $392,215 | $602,976 |
| 2019 | Krystal Biotech, Inc. (KRYS) | Chief Operating Officer | $305,642 | $305,642 |
| 2018 | Krystal Biotech, Inc. (KRYS) | Chief Operating Officer | $200,000 | $495,444 |
